New anticancer agents.
Weiss
G R
GR
Department of Medicine, University of Texas Health Science Center, San Antonio, USA.
Burris
H A
HA
Eckardt
J R
JR
Fields
S
S
O'Rourke
T
T
Rodriguez
G I
GI
Rothenberg
M L
ML
D000225:Adenine; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002166:Camptothecin / Q000031:analogs & derivatives / Q000494:pharmacology; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D007094:Imides / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D000077146:Irinotecan; D007546:Isoquinolines / Q000494:pharmacology; D053644:Naphthalimides; D063065:Organophosphonates; D011725:Pyridines / Q000494:pharmacology; D019772:Topotecan; D014747:Vinblastine / Q000031:analogs & derivatives / Q000494:pharmacology; D000077235:Vinorelbine; D000093542:Gemcitabine
D000970:Antineoplastic Agents; D007094:Imides; D007211:Indoles; D007546:Isoquinolines; D053644:Naphthalimides; D063065:Organophosphonates; D011725:Pyridines; D003841:Deoxycytidine; C037020:amonafide; D014747:Vinblastine; D000077146:Irinotecan; D019772:Topotecan; C081834:intoplicine; D000225:Adenine; D000077235:Vinorelbine; D002166:Camptothecin; D000093542:Gemcitabine